NGFR and cancer: Combined with the western blot results, these results suggested that CD271 and SOX10, which have been recognized as indicators of melanoma stemness, were highly expressed in A2058R and OE cells (Figure 4i), indicating that PCK1 could modify cancer stemness in the development of drug resistance.